Skin Grafting System Market Research Report and Outlook by 2028

The skin grafting system market is anticipated to grow significantly, reaching an estimated US$ 1,348.21 million by 2028, up from US$ 832.44 million in 2021. This growth represents a compound annual growth rate (CAGR) of 7.1% from 2021 to 2028. The report outlines the prevailing trends and key factors propelling market expansion. The increase in skin grafting system demand is primarily driven by the rising incidence of burn injuries, the growing prevalence of skin cancer and diabetes, and the expanding range of skin graft sources available. However, the high costs associated with skin grafting procedures pose a challenge to market growth.

The main applications for skin grafts include treating burns and skin infections. The number of fatalities resulting from burn injuries has been alarming. According to the American Burn Association, in 2016, there were 3,390 civilian deaths in the US due to fire incidents, which included 2,800 deaths from residential fires, 150 from non-residential fires, 355 from vehicle fires, and 85 from other types of fires. Additionally, over 14,650 injuries were reported. Between 2011 and 2018, there were 58,520 injuries among firefighters in the US. The National Fire Protection Association (NFPA) reported that in 2020, there were 1,388,500 fires, resulting in 3,500 civilian deaths and 15,200 injuries. Although fire-related deaths have decreased by 46% since 1980, there was a 23% increase from the record low of 2,855 deaths in 2012 to the current figures. The NFPA also noted that one- and two-family home fires accounted for 63.7% of civilian casualties and 56.6% of injuries, with apartment fires contributing 19.1% of injuries in 2020.

Globally, the World Health Organization (WHO) reported in 2018 that over 180,000 deaths occur annually due to burns, predominantly in low- to middle-income countries in Africa and Southeast Asia. For example, it is estimated that in India, around one million people suffer moderate to severe burns each year. In countries like Bangladesh, Colombia, Egypt, and Pakistan, 17% of childhood burn cases result in temporary disabilities, while 18% lead to permanent disabilities. The increasing incidence of burn injuries has led to a heightened demand for skin grafts to repair damaged skin. According to the National Burn Repository (NBR), approximately 486,000 burn injuries required medical treatment in 2016, with over 60% of hospitalizations occurring in 128 specialized burn centers. The financial burden of treatment has also escalated; for instance, in 2017, the National Health Services (NHS) in the UK treated around 15,000 patients for burn injuries at a cost exceeding US$ 24.94 million (approximately GBP 20 million). In the US, the annual expenditure on emergency room visits and hospital care for burn injuries exceeds US$ 7.9 billion.

The rising number of burn injuries has prompted healthcare systems to establish comprehensive burn care programs. For instance, Saudi Arabia has initiated a national burn care program, establishing 17 burn care facilities across the country. Institutions like the Burn Unit and Plastic Surgery Department at Prince Sultan Military Medical City (PSMMC) offer skin grafting services and long-term rehabilitation, reflecting the growing need for effective burn treatment solutions.

The skin grafting system market is categorized by product type into dermatomes, wound debridement devices, skin graft mesher equipment and accessories, among others. In 2021, the wound debridement devices segment held the largest market share, while the dermatomes segment is projected to experience the highest CAGR during the forecast period. The market is also divided by graft type into autografts and allografts, with autografts dominating the market in 2021. The burns segment accounted for the largest share based on wound type, although the surgical wounds segment is expected to grow at the highest CAGR. In terms of end users, hospitals represented the largest segment in 2021 and are expected to maintain a dominant position throughout the forecast period.

The COVID-19 pandemic has significantly impacted the healthcare sector, leading to a public health crisis and economic downturn in many regions. The initial phase of the pandemic saw a substantial decline in healthcare services, with numerous elective procedures being postponed or canceled, which adversely affected the volume of skin grafting procedures. As skin grafting is often categorized as elective, the demand for these procedures diminished, leading to a reduction in the need for related consumables and instruments. Furthermore, the pandemic disrupted product development and innovation, as many medical device companies shifted their focus to urgent pandemic-related solutions. Supply chain disruptions also hindered the ability to meet market demands due to production delays and raw material shortages. However, as vaccination efforts progressed and restrictions on elective surgeries eased, the skin grafting systems market began to recover.

Companies in the skin grafting system market have adopted various organic and inorganic growth strategies. Organic strategies include product launches and approvals, while inorganic strategies involve acquisitions, collaborations, and partnerships. These strategies enable companies to expand their market presence and enhance their product offerings. Notable developments in the market include:

• In May 2021, Exsurco Medical launched a mobile app designed to support its Amalgatome SD device, providing training resources for healthcare professionals.


• In July 2021, CEECAT Capital acquired a majority stake in Aygun Surgical Instruments, aiming to bolster Aygun's growth in Western Europe and strengthen its global presence.

Key sources referenced in the preparation of this report include information bulletins, statistics, and press releases from the International Diabetes Federation (IDF), World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC).